We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HP icon
201
Helmerich & Payne
HP
$3.53B
$8.42M 0.12%
130,236
+2,906
+2% +$163K
PII icon
202
Polaris
PII
$4.15B
$7.84M 0.12%
63,264
+300
+0.5% +$35.6K
CLB icon
203
Core Laboratories
CLB
$538M
$7.74M 0.11%
70,661
-3,769
-5% -$376K
WASH icon
204
Washington Trust Bancorp
WASH
$732M
$7.73M 0.11%
145,180
-3,239
-2% -$180K
MTB icon
205
M&T Bank
MTB
$36.2B
$7.66M 0.11%
44,792
-150
-0.3% -$24.9K
CRVL icon
206
CorVel
CRVL
$3.05B
$7.37M 0.11%
418,026
-9,234
-2% -$174K
INTC icon
207
Intel
INTC
$466B
$7.28M 0.11%
157,787
+382
+0.2% +$16.7K
EG icon
208
Everest Group
EG
$15.2B
$7.14M 0.1%
32,262
-28
-0.1% -$6.31K
OII icon
209
Oceaneering
OII
$5.25B
$6.95M 0.1%
328,875
-50,500
-13% -$1.07M
JKHY icon
210
Jack Henry & Associates
JKHY
$10.7B
$6.92M 0.1%
+59,131
New +$6.61M
NGS icon
211
Natural Gas Services Group
NGS
$470M
$6.9M 0.1%
263,228
-6,615
-2% -$176K
TUP
212
DELISTED
Tupperware Brands Corporation
TUP
$6.89M 0.1%
109,855
-3,250
-3% -$199K
CHRW icon
213
C.H. Robinson
CHRW
$22B
$6.68M 0.1%
74,962
+1,541
+2% +$126K
JWN
214
DELISTED
Nordstrom
JWN
$6.54M 0.1%
137,996
-2,163
-2% -$93.2K
GABC icon
215
German American Bancorp
GABC
$1.82B
$6.22M 0.09%
175,989
+46,338
+36% +$1.69M
DCOM icon
216
Dime Commercial Bancshares
DCOM
$1.75B
$6.17M 0.09%
176,158
-4,419
-2% -$154K
CHKP icon
217
Check Point Software Technologies
CHKP
$13.3B
$6.09M 0.09%
58,801
-4,435
-7% -$482K
TIF
218
DELISTED
Tiffany & Co.
TIF
$5.92M 0.09%
56,993
+462
+0.8% +$44K
AAP icon
219
Advance Auto Parts
AAP
$3.37B
$5.46M 0.08%
54,758
-6,135
-10% -$564K
TJX icon
220
TJX Companies
TJX
$170B
$5.28M 0.08%
137,986
-200
-0.1% -$7.25K
VCIT icon
221
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$5.21M 0.08%
59,562
-654
-1% -$57.3K
H icon
222
Hyatt Hotels
H
$17.6B
$5.18M 0.08%
70,425
+8,865
+14% +$600K
KSU
223
DELISTED
Kansas City Southern
KSU
$4.69M 0.07%
44,547
+707
+2% +$75.4K
ATO icon
224
Atmos Energy
ATO
$29.9B
$4.66M 0.07%
+54,310
New +$4.78M
AME icon
225
Ametek
AME
$55.5B
$4.56M 0.07%
62,905
-3,510
-5% -$245K

Similar funds

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.